Publicly-Held Company

Corporate Taxpayer's ID No. 60.746.948/0001-12

COMMUNICATION ON RELATED-PARTY TRANSACTIONS

Medical Services

Banco Bradesco S.A. ("Bradesco" or "Company") informs its shareholders and the market in general, in accordance with Article 30 and Exhibit 30-XXXVI of Securities and Exchange Commission ("CVM") Instruction No. 480/09 and Related-Party Transactions Policy of the Company ("Internal Policy") that, on this date, the Operational Agreement initiated in April of this year between Fleury S.A. ("Fleury") and Bradesco Saúde S.A. ("Bradesco Saúde"), Bradesco´s wholly-owned subsidiary, with the purpose of carry out COVID-19 tests in Bradesco Organization´s employees and their dependents who are beneficiaries of Bradesco Saúde ("Transaction"), was finalized.

The information referring to the Transaction, provided in the aforementioned CVM Instruction, are listed in the chart below:

Transaction

Related-Party´s Name

Fleury

Bradesco holds, direct and indirectly, 100% of the capital of

Relation between the Related-

Bradseg Participações S.A. ("Bradseg") and Bradesco Saúde.

Party and the Company

Bradseg holds around 22% of the shares issued by Fleury.

Medical Services provided by Fleury, in the area of diagnostics

Transaction´s Subject

tests and clinical analyses relating to the performance of

COVID-19 tests, to Bradesco Organization´s employees and

their dependents, who are beneficiaries of Bradesco Saúde.

Signature Date: 12.30.2020.

Duration: In effect until 04.16.2021 and may be extended by

prior agreement between the parties. The Operational

Agreement will start on this date, with its legal effects

Main Terms and Conditions

retroactively to 04.17.2020.

Total Amount: R$ 63,000,000.00 (sixty three million reais).

Method of payment: monthly instalment, according to the

quantity and type of tests actually performed.

If, when, how and to what extend

the

counterparty

in

the

transaction,

its

partners

or

Not applicable.

managers

participated

in

the

process

Detailed

justification

of

the

The Company´s Management understands that the

reasons

why

the

issuer's

Transaction observed commutative conditions and provides

Management

considers

that

the

for adequate compensatory payment, since was carried out in

Transaction

observed

the best interest of the Company, observing Market Conditions

commutative

conditions

or

(according to the Company's Internal Policy), good governance

provides

for

adequate

practices, conduct, ethics and transparency and no Conflicts of

compensatory payment

Interest (according to the Company's Internal Policy).

The documents referring to the Transaction are filed at the Company´s

headquarters.

Cidade de Deus, Osasco, SP, December 30, 2020.

Banco Bradesco S.A.

Leandro de Miranda Araujo

Deputy Executive Officer and

Investor Relations Officer

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Banco Bradesco SA published this content on 30 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 December 2020 23:26:02 UTC